Skip to main content
  • MIPS 2021—Key Dates for Performance Year 2021

    This content is excerpted from EyeNet’s MIPS 2021; also see the Academy’s MIPS hub page.


    2020  
    Dec. 1 CMS posts the 2021 QPP rule online. On Dec. 28, the agency formally publishes it in the Federal Register Vol. 85(248):88472-85377.
    Dec. 31 Deadline to form a virtual group for the 20121 performance year.
    2021  
    Jan. 1 Start of 2021 performance year.
    May CMS started accepting applications for (1) extreme and uncontrollable circumstances exceptions and (2) hardship exception to PI performance category.
    June 1 Deadline for new IRIS Registry users to sign agreements for IRIS Registry–EHR integration (if not already integrated).
    June 15 Deadline for notifiying the IRIS Registry vendor about significant changes to your EHR system, such as a system upgrade, a move to a cloud-based system, or a move to another EHR system.
    Aug. 1 Deadline for integrating your EHR system with the IRIS Registry for automated transmission of 2021 quality data.
    Aug. 31 Deadline for submitting your improvement plan to the American Board of Ophthalmology for the MOC improvement activity (see https://abop.org/IRIS).
    Aug. 31 Deadline to add new clinicians for practices reporting via IRIS Registry–EHR integration.
    Oct. 3 Last day to start performance period for PI measures and improvement activities.
    Oct. 31 Deadline for new IRIS Registry users to sign agreements to use the IRIS Registry for manual reporting of improvement activities, PI measures, and quality measures.
    Oct. 31 Last day to request IRIS Registry mapping refinements for selected quality measures. (Note: This extended deadline replaces the Sept. 30 deadline that had been published earlier.)
    Dec. 31

    Application deadline for (1) extreme and uncontrollable circumstances exceptions and (2) hardship exception to PI performance category.

    Dec. 31

    End of 2021 performance year.

    2022  
    Jan. 31

    Deadline to submit your 2021 IRIS Registry data release consent form.

    Deadline for IRIS Registry users to enter 2021 quality measure data, attest to PI measures, and attest to improvement activities.

    March 31 Last day to submit 2021 MIPS data if reporting directly to the CMS QPP attestation portal.
    July

    CMS will provide you with feedback based on your 2021 performance year data.

    Targeted review starts after release of feedback data.

    Aug. 31 Targeted review ends.
    Dec. 1 CMS must notify MIPS participants of their 2023 payment adjustment factor at least 30 days before the 2021 payment year.
    2023  
    Jan. 1 Your Medicare Part B reimbursements will be adjusted up or down based on your 2019 MIPS performance.

    CMS Status Determination Time Segments for Performance Year 2021

    MIPS Pathway
    MIPS Determination Period: Segment 1 Oct. 1, 2019–Sept. 30, 2020 (plus a 30-day claims run out)
    MIPS Determination Period: Segment 2 Oct. 1, 2020–Sept. 30, 2021 (no claims run out)

    Previous: Are You In a Small Practice With No EHR?

    Next: Your Guide to MIPS Acronyms

    DISCLAIMER AND LIMITATION OF LIABILITY: Meeting regulatory requirements is a complicated process involving continually changing rules and the application of judgment to factual situations. The Academy does not guarantee or warrant that regulators and public or private payers will agree with the Academy’s information or recommendations. The Academy shall not be liable to you or any other party to any extent whatsoever for errors in, or omissions from, any such information provided by the Academy, its employees, agents, or representatives.

    COPYRIGHT© 2021, American Academy of Ophthalmology, Inc.® All rights reserved. No part of this publication may be reproduced without written permission from the publisher. American Academy of Ophthalmic Executives® and IRIS® Registry, among other marks, are trademarks of the American Academy of Ophthalmology®.

    All of the American Academy of Ophthalmology (AAO)–developed quality measures are copyrighted by the AAO’s H. Dunbar Hoskins Jr., MD, Center for Quality Eye Care (see terms of use).